top of page
General Genomics Inc.
General Genomics SAFE 1
Accurately predict your risk of infectious disease (like COVID) and take control
There is a newer open investment round for this company - click here to view
Our take:
The company relies on layering AI over a myriad of data sources, including electronic medical records. Given the difficult of even having & accessing centralized electronic medical records for an individual (let alone a collective group), the company's high valuation, and focus on COVID as a buzzword/sales pitch make this a non-starter in our view. (1/10/2021)
Sign up to receive weekly deal alerts and top news
Round Performance
Amount Raised
[]
Average Investment
[]
Average Per Day
[]
# of Investors
[]
Investors vs. Capital Raised
Investment Type
SAFE
Valuation Cap
$50,000,000
Minimum Investment
$100
Conversion Discount
Investment Details
Early Bird Perks
Perk description | Perk level (dollars) | Perk level (days) |
|---|
Loading...
Similar Investments
Geoship
SAFE
KALIA HEALTH
OPTICYTE
bottom of page